Brief: Sienna Biopharmaceuticals Initiates Voluntary Chapter 11 Protection Proceeding

Sienna Biopharmaceuticals

17/09/2019 13:41

Sept 17 (Reuters) - Sienna Biopharmaceuticals Inc  SNNA.O :
    * SIENNA BIOPHARMACEUTICALS INITIATES VOLUNTARY CHAPTER 11
PROTECTION PROCEEDING
    * SIENNA BIOPHARMACEUTICALS - ELECTED TO FILE A VOLUNTARY
PETITION
TO ALLOW RESTRUCTURING UNDER CHAPTER 11 OF BANKRUPTCY CODE
    * SIENNA BIOPHARMACEUTICALS - EXPECT TO MAINTAIN ONGOING
BUSINESS
ACTIVITIES WHILE WE CONTINUE TO LOCATE PURCHASER OR STRATEGIC
PARTNER
    * SIENNA BIOPHARMACEUTICALS - RETAINED LATHAM & WATKINS AS
LEGAL
COUNSEL, COWEN AND COMPANY AS INVESTMENT BANK TO REVIEW
FINANCIAL & STRATEGIC ALTERNATIVES

Source text for Eikon:  ID:nGNX8ZMwqW 
Further company coverage:  SNNA.O 

 ((Reuters.Briefs@thomsonreuters.com;))